Boston Scientific Awarded CRM Contract by Department of Veterans Affairs

 
January 20, 2009

January 20, 2009 - Boston Scientific Corp. today said it was awarded a contract by the U.S. Department of Veterans Affairs (VA) for a full line of the company’s pacemakers and defibrillators.

The one-year contract took effect last month and has annual renewal options for up to four years. It includes Boston Scientific’s newest technologies in both product categories: the ALTRU family of pacemakers and the TELIGEN implantable cardioverter defibrillator.

The contract provides Boston Scientific the opportunity to supply life-saving and life-improving therapies to VA patients at risk of sudden cardiac death and bradycardia arrhythmias. Overall patient enrollment at VA Medical Centers has increased from 4.8 million in 2000 to 8 million in 2008 and is projected to continue growing.

For more information: www.bostonscientific.com

More like this

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Related News

Nearly 50 Percent of Patients With Cardiac Device Infections Don’t Survive Beyond Three Years

May 16, 2013 — The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and...

St. Jude Medical Enrolls First Patient in Next-Generation Quadra Study

May 6, 2013 — St. Jude Medical announced its first enrollment in its MultiPoint Pacing clinical study to build upon its first- to-market quadripolar pacing system. Patients will be implanted...

St. Jude Medical Gains European Approval for First Quadripolar CRT Pacemaker

April 30, 2013 — St. Jude Medical Inc. announced CE Mark approval and European launch of its Allure Quadra ...

View all

Related Articles

Nearly 50 Percent of Patients With Cardiac Device Infections Don’t Survive Beyond Three Years

May 16, 2013 — The incremental mortality in implantable pacemaker and defibrillator recipients who experience a device infection, compared to patients without device infection, is substantial and...

Medtronic Announces FDA Approval, Launch of Advisa MRI Pacemaker System

February 18, 2013 — Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of its Advisa DR...

FDA Clears St. Jude’s New Version of Remote Patient Monitoring System

January 16, 2013 — The U.S. Food and Drug Administration (FDA) has cleared St. Jude Medical’s new version of its Merlin.net Patient Care Network (PCN).

View all